Abstract: Merkel cell carcinoma (MCC) is a rare and highly aggressive cutaneous carcinoma with characteristics of neuroendocrine tumor. We performed immunohistochemical analysis to demonstrate the presence of various neuropeptides within cells of MCC resected from a 75-year old woman. The cells of primary tumor of cheek were compared with the cells of regional right submandibular metastatic tumor which was found eight months later. A double-staining IHC for the pan-neuronal marker, PGP 9.5, and selected neuropeptides in the tissue material obtained from both locations was performed. Single multipolar cells in the main mass of primary tumor stained positively for PGP 9.5 and such neuropeptides as GAL, VIP, PACAP, NPY and CGRP. Moreover, we demonstrated for the first time the presence of neuropeptides in metastatic MCC cells. In the metastatic tumor, cells showing the co-localization of PGP-9.5 and neuropeptides were more numerous, mostly of oval shape, and significantly smaller than in the primary tumor. Thus, the progression of MCC may be associated with the acquisition by its cells of new morphological and biological features.
Introduction
Merkel cell carcinoma (MCC) is a rare and highly aggressive cutaneous tumor. Its true origin has not been proved definitively. The presence of electron-dense neurosecretory granules in the tumor cells led to its classification among the neuroendocrine carcinomas. As Merkel cells, which belong to the amine precursor uptake and decarboxylation system (APUD), are the only cutaneous cells that possess such granules, it is believed that MCC is derived from these cells [1] . The numerous secretory vacuoles of Merkel cells contain many biologically active substances such as vasoactive intestinal peptide (VIP), substance P (SP), calcitonin gen-related peptide (CGRP), galanin (GAL) and neuropeptide Y (NPY) [2] [3] [4] [5] [6] . Moreover, Merkel cells stain positively for the nervous and neuroendocrine cell markers such as protein gene-product 9.5 (PGP 9.5) and chromogranin A [7, 8] . Interestingly, in primary MCC the presence of some neuropeptides was demonstrated only in a part of investigated tumors [9] [10] . Since the presence of neuropeptides in the metachronous metastatic MCC tumor as well as the 
Material and methods
MCC tissue was obtained from a 75-year-old female who had the skin tumor of the upper part of right cheek/lower eyelid. Detailed clinical examinations revealed lack of any others diseases. The tumor was removed within the margin of macroscopically healthy tissues, and the loss of skin was reconstructed with a rotation flap. Macroscopically, it was a pale-cream colored tumor with the dimensions of 1.6×1.6×2 cm, covered with epidermis. It was diagnosed by pathologist on the basis of the examination in hematoxylin-eosin (H&E) stained slides ( Figure 1A ) as a small cell type of MCC (small cell type of MCC), with immunohistochemical characteristics such as the presence of cytokeratine 20 (CK20)/+/ ( Figure 1B) , and CD56/+/, chromogranin /+/, synaptophysin/+/ (not shown). The rapid recurrence within the postoperative scar, after 6 weeks from the first operation was observed. The recurrence was excised and the extensive loss of the skin was supplemented with plastics by free flap of the skin.
In the course of further observation, local recurrence was not observed within this region, however, after 8 months the metastatic tumour grew in the right submandibular area. For this reason, the patient underwent surgery and the tumor was removed. The histopathological assessment confirmed the metastasis of MCC with the same histological and immunohistochemical characteristics as the primary tumor.
Immunofluorescence analysis. To assess the presence of neuropeptides, after histopathological assessment of the primary and metastatic, serial paraffin sections were obtained and double-stained by immunofluorescent technique to check for the presence of PGP 9.5, and several neuropeptides (VIP, PACAP, NPY, CGRP, GAL). www.fhc.viamedica.pl
Discussion
The origin and etiology of MCC are still controversial. There are differences and similarities between Merkel cells and the cells of MCC. Although Merkel cells are abundant in areas of skin involved in touch perception (e.g. finger tips), this location is uncommon for MCC. Moreover, the cells of MCC do not express the opioid peptides identified in normal Merkel cells [11] . On the other hand, ultrastructural studies revealed the presence of dense-core neuroendocrine granules in the cytoplasm of tumor [16] . A large-cell type often has a trabecular pattern and a high density of granules at the ultrastructural level, while the ultrastructure of a small-cell type reveals paucity of granules and resemblance to skin metastases of small-cell lung carcinoma [17] . In contrast to a study by Sandel et al. [18] , Skelton et al. [19] observed a correlation between small cell type predominance and poor prognosis. The small cell growth pattern is a characteristic feature of a one subtype of MCC invasion. The small cell morphology was found to be associated with high biological malignancy, fast growth, as well as early formation of metastases [20] . Neuropeptides can function as autocrine growth factors in cancer cells. Previous studies confirmed presence of neuropeptides in different types of cancers, e.g. PACAP in prostate and breast cancer or VIP and NPY in prostate and urinary bladder cancer [21] [22] [23] . Further investigations established the presence of neuropeptide receptors, e.g. VPAC1, VPAC2 and PACAP receptors, respectively, in prostate, breast and lung cancer tissues [24] [25] [26] [27] [28] . The occurrence of neuropeptides and their receptors within tumor may strongly suggest an autocrine pattern of signaling resulting in a faster tumor growth. In the small cell lung cancer (SCLC), stimulation of VPAC1 and PAC1 receptors increased the levels of intracellular cAMP, as well as activated tyrosine kinase cellular pathways [29] . It was also shown that VIP caused the release of BB (bombesin)-like peptides from SCLC cells, which in an autocrine manner, via BB2 bombesin receptors and mitogen activated protein kinase (MAPK) pathway increased expression of cell growth factors [30] . Moreover, an oncogenic impact of GAL receptor via elevation of intracellular ionized calcium concentration was also found in SCLC [31] . Furthermore, it was shown that CGRP increased the invasive potential of prostate cancer cells partially by the enhancement of cell motility [32] . The previously described presence of neuropeptides and their receptors within Merkel cells of a normal epidermis may suggest a possible autocrine function of the neuropeptides in Merkel cells [5] .
Microscopic observations carried out within this study for the first time showed the presence of GAL, VIP, PACAP, NPY and CGRP within cells of not only primary but also metastatic MCC. We also observed neuropeptidergic plasticity of the neoplastic cells comparing these two MCC locations. The increase in the number of phenotypically different neuropeptidecontaining cells in metastatic MCC suggests that the neuropeptides may accelerate tumor's growth and its invasiveness.
